System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Nikolaus Marx, MD is an expert in Cardiology at Universitätsklinikum Aachen (Germany). As of October 2026, ScienceLeadR ranks Nikolaus Marx in the top 1% of experts worldwide for Diabetes Mellitus, Glucose Metabolism Disorders and Heart Failure. Nikolaus Marx has authored 912 publications, the most recent in 2026, and is an investigator in 33 clinical trials, 1 of them ongoing. SLR score: 3,300 (community average: 125). How the SLR is computed.

LeadR Profile

Nikolaus Marx, MD Universitätsklinikum Aachen Germany
3 300 ScienceLeadR Reputation 3300

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Endocrinology - Nephrology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026
Source: PubMed

Universitätsklinikum Aachen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 912

Citations

Citations: 44 350 1st author: 59 Last author: 120 Unique author: 42

Main journals

Eur Heart J 108
Dtsch Med Wochenschr 29
Clin Res Cardiol 27
J Am Coll Cardiol 25
Cardiovasc Diabetol 23

Best Journals

Eur Heart J 36
Circulation 7
Lancet Diabetes Endocrinol 5

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
C-reactive protein and mortality in 'SMuRF-less but inflamed' women and men: Evidence from the United Kingdom Biobank.
PMID 42893168 — mortality, c-reactive protein		Am J Prev Cardiol20261
A Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted.
PMID 42853614 — diabetes mellitus, therapeutics, diabetes mellitus, type 2		J Am Soc Nephrol20260
Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration.
PMID 42758309 — atrial fibrillation, sex		Europace20260
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes.
PMID 42697978 — kidney diseases, c-reactive protein, kidney, therapeutics		Nat Rev Nephrol Top journal20261
Great debate: diabetic cardiomyopathy is a distinct disease.
PMID 42681860 — diabetic cardiomyopathies, cardiology, cardiomyopathies		Eur Heart J Top journal20260

Clinical Studies 33

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 18
Phase 3 9
Phase 4 3
Phase 2 2
Phase 1 1

By status:

Completed 26
Terminated 3
Active not recruiting 1
Recruiting 1
Suspended 1
Unknown 1

By type:

Interventional 22
Observational 11

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 2
multicentric5to9 0
multicentricup10 14

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Non invasive Differentiation of Supraventricular Tachyarrhythmia
NCT06061120 — arrhythmias, cardiac, atrial fibrillation, tachycardia, therapeutics, tachycardia, supraventricular, electrocardiography		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS